UK life sciences are thriving despite Covid-19 – but choppy waters lie ahead 15 Apr 2021 We’ve seen a surge in commercial investment in UK life sciences, driven by world-class interactions between academia and industry. But cuts to Government and charity funding for academic research could put that all at risk, says Angela Kukula, Director of Business and Innovation at the ICR. Find out more Show/Hide
Ten lessons for the life sciences from COVID-19 07 Dec 2020 Dr Angela Kukula, the ICR’s Director of Business and Innovation, asks what the future holds for the life sciences after the COVID-19 pandemic – and how we can ensure the rapid development of COVID-19 technologies happens in other areas too. Find out more Show/Hide
What are the biggest issues in drug discovery and development? 09 Nov 2020 Our programme of expert summits is proposing solutions to some of the biggest issues in drug discovery and development, says Director of Business and Innovation Dr Angela Kukula. Find out more Show/Hide
Cancer research collaborations in the era of COVID-19: force majeure, home working and supporting the NHS 23 Apr 2020